Shares in Tissue Regenix Group PLC (AIM:TRX) will begin trading on a private secondary market on Wednesday after the company’s departure from London’s junior AIM market formally takes effect.
From today, trading in Tissue Regenix shares will be handled by Asset Match, which will operate an electronic, off-market dealing facility. Asset Match is authorised and regulated by the Financial Conduct Authority.
Rather than continuous trading, as on a public stock market, shares will change hands through periodic auctions.et structure instead.